169 related articles for article (PubMed ID: 20805247)
1. MEF/ELF4 transactivation by E2F1 is inhibited by p53.
Taura M; Suico MA; Fukuda R; Koga T; Shuto T; Sato T; Morino-Koga S; Okada S; Kai H
Nucleic Acids Res; 2011 Jan; 39(1):76-88. PubMed ID: 20805247
[TBL] [Abstract][Full Text] [Related]
2. The transcription factor MEF/Elf4 is dually modulated by p53-MDM2 axis and MEF-MDM2 autoregulatory mechanism.
Suico MA; Fukuda R; Miyakita R; Koyama K; Taura M; Shuto T; Kai H
J Biol Chem; 2014 Sep; 289(38):26143-26154. PubMed ID: 25081543
[TBL] [Abstract][Full Text] [Related]
3. Mdm2 inhibition of p53 induces E2F1 transactivation via p21.
Wunderlich M; Berberich SJ
Oncogene; 2002 Jun; 21(28):4414-21. PubMed ID: 12080472
[TBL] [Abstract][Full Text] [Related]
4. ELF4/MEF activates MDM2 expression and blocks oncogene-induced p16 activation to promote transformation.
Sashida G; Liu Y; Elf S; Miyata Y; Ohyashiki K; Izumi M; Menendez S; Nimer SD
Mol Cell Biol; 2009 Jul; 29(13):3687-99. PubMed ID: 19380490
[TBL] [Abstract][Full Text] [Related]
5. E2F1 inhibits MDM2 expression in a p53-dependent manner.
Tian X; Chen Y; Hu W; Wu M
Cell Signal; 2011 Jan; 23(1):193-200. PubMed ID: 20837136
[TBL] [Abstract][Full Text] [Related]
6. E2F1-mediated transcriptional inhibition of the plasminogen activator inhibitor type 1 gene.
Koziczak M; Müller H; Helin K; Nagamine Y
Eur J Biochem; 2001 Sep; 268(18):4969-78. PubMed ID: 11559366
[TBL] [Abstract][Full Text] [Related]
7. The proapoptotic gene SIVA is a direct transcriptional target for the tumor suppressors p53 and E2F1.
Fortin A; MacLaurin JG; Arbour N; Cregan SP; Kushwaha N; Callaghan SM; Park DS; Albert PR; Slack RS
J Biol Chem; 2004 Jul; 279(27):28706-14. PubMed ID: 15105421
[TBL] [Abstract][Full Text] [Related]
8. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.
Hsieh JK; Fredersdorf S; Kouzarides T; Martin K; Lu X
Genes Dev; 1997 Jul; 11(14):1840-52. PubMed ID: 9242491
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315.
Fogal V; Hsieh JK; Royer C; Zhong S; Lu X
EMBO J; 2005 Aug; 24(15):2768-82. PubMed ID: 16037820
[TBL] [Abstract][Full Text] [Related]
10. Activation of the murine dihydrofolate reductase promoter by E2F1. A requirement for CBP recruitment.
Fry CJ; Pearson A; Malinowski E; Bartley SM; Greenblatt J; Farnham PJ
J Biol Chem; 1999 May; 274(22):15883-91. PubMed ID: 10336493
[TBL] [Abstract][Full Text] [Related]
11. Role of the p53-homologue p73 in E2F1-induced apoptosis.
Stiewe T; Pützer BM
Nat Genet; 2000 Dec; 26(4):464-9. PubMed ID: 11101847
[TBL] [Abstract][Full Text] [Related]
12. MEF, a novel transcription factor with an Elf-1 like DNA binding domain but distinct transcriptional activating properties.
Miyazaki Y; Sun X; Uchida H; Zhang J; Nimer S
Oncogene; 1996 Oct; 13(8):1721-9. PubMed ID: 8895518
[TBL] [Abstract][Full Text] [Related]
13. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.
Ou YH; Chung PH; Hsu FF; Sun TP; Chang WY; Shieh SY
EMBO J; 2007 Sep; 26(17):3968-80. PubMed ID: 17690688
[TBL] [Abstract][Full Text] [Related]
14. E2F1 activates the human p53 promoter and overcomes the repressive effect of hepatitis B viral X protein (Hbx) on the p53 promoter.
Choi M; Lee H; Rho HM
IUBMB Life; 2002 Jun; 53(6):309-17. PubMed ID: 12625370
[TBL] [Abstract][Full Text] [Related]
15. JAZ mediates G1 cell cycle arrest by interacting with and inhibiting E2F1.
Yang M; Wu S; Jia J; May WS
Cell Cycle; 2011 Jul; 10(14):2390-9. PubMed ID: 21715977
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
17. p53-dependent down-regulation of telomerase is mediated by p21waf1.
Shats I; Milyavsky M; Tang X; Stambolsky P; Erez N; Brosh R; Kogan I; Braunstein I; Tzukerman M; Ginsberg D; Rotter V
J Biol Chem; 2004 Dec; 279(49):50976-85. PubMed ID: 15371422
[TBL] [Abstract][Full Text] [Related]
18. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.
Hershko T; Chaussepied M; Oren M; Ginsberg D
Cell Death Differ; 2005 Apr; 12(4):377-83. PubMed ID: 15706352
[TBL] [Abstract][Full Text] [Related]
19. Direct repression of the Mcl-1 promoter by E2F1.
Croxton R; Ma Y; Song L; Haura EB; Cress WD
Oncogene; 2002 Feb; 21(9):1359-69. PubMed ID: 11857079
[TBL] [Abstract][Full Text] [Related]
20. The oncogenic role of the ETS transcription factors MEF and ERG.
Sashida G; Bazzoli E; Menendez S; Liu Y; Nimer SD
Cell Cycle; 2010 Sep; 9(17):3457-9. PubMed ID: 20814243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
